1 / 21

HYPERSENSITIVITY

HYPERSENSITIVITY. Lecture 9 Jan Żeromski. POINTS TO BE DISCUSSED. Definition of hypersensitivity Four types of hypersensitivity Type I – anaphylactic Type II – cytotoxic Type III – immune complex mediated Type IV – contact, tuberculin and granulomatous.

fai
Télécharger la présentation

HYPERSENSITIVITY

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HYPERSENSITIVITY Lecture 9 Jan Żeromski

  2. POINTS TO BE DISCUSSED • Definition of hypersensitivity • Four types of hypersensitivity • Type I – anaphylactic • Type II – cytotoxic • Type III – immune complex mediated • Type IV – contact, tuberculin and granulomatous

  3. HYPERSENSITIVITY TYPE I – KEY POINTS • IgE antibody response directed against innocuous environmental Ag’s such as animal dander, house-dust mites, pollen, industrial pollutants, etc. • IgE becomes coated on mast cells or basophiles via their Fc receptors

  4. HYPERSENSITIVITY TYPE I – KEY POINTS - 2 • Binding of allergen by IgE results in degranulation of mast cells and mediator release • Allergic manifestations ensue such as hay fever, asthma, skin eczema, anaphylaxis

  5. TYPE I HYPERSENSITIVITY IN HOST DEFENSE IN THE AFFERENT IMMUNE RESPONSE • IgE-mediated allergen capture • IgE-mediated allergen processing • IgE-mediated allergen presentation • Immune deviation toward Th2 responses via release of key cytokines via innate immune responses

  6. EXAMPLES AND SYMBOLS OF PURIFIED ALLERGENS • Betula verrucosa (birch) - Bet v 1 • Corylus avellana (hazel) - Cor a 1 • Felis domesticus (cat) - Fel d 1 • Rattus norvegicus (rat) - Rat n 1, n 2 • Cavia porcellus (guinea pig) – Cav p 1 • Equus caballus (horse) - Equ c 1 • Gallus domesticus (hen) - Gal d 1 • Apis mellifera (honey-bee) - Api m 1 • Arachis hypogea (nuts) - Ara h 1

  7. TYPE I HYPERSENSITIVITY IN HOST DEFENSE IN THE EFFERENT IMMUNE RESPONSE • Induction of mast cells and basophil early phase by innate immunity (complement, defensins) • Induction of mast cells and basophile early phase by IgE antibody

  8. TYPE I HYPERSENSITIVITY IN HOST DEFENSE IN THE EFFERENT IMMUNE RESPONSE • Induction of IgE-mediated antibody-dependent cellular cytotoxicity (ADCC) and release of inflammatory molecules from macrophages, eosinophils and neutrophils • Induction of Th2 CD4+ cells with their direct and indirect participation in thehost response

  9. MCT tryptase positive Equivalent of mucosal mast cells in rodents Produce preferentially IL-5 and Il-6 Sodium cromoglycane (Intal) sensitive MCTC tryptase and chymase positive Equivalent of connective tissue MC Produce preferentially IL-4 Sodium cromoglycane insensitive Functionally more mature than MCT TWO TYPES OF MAST CELLS IN MAN

  10. FACTORS REGULATING THE LEVEL OF TYPE I HYPERSENSITIVITY • Genetic linkage controlling total IgE level • HLA-D encoded genes for allergen-specific response • Allergen-driven Th2 predominance • Effects of environmental exposures • Individual sensitivity to inflammatory mediators

  11. ASTHMA PATHOGENESIS • It is a chronic inflammatory disorder of the airways: mucosal inflammation, reversible airway obstruction, bronchial hyperresponsiveness • Bronchial epithelium, mast cells, T-helper cells and eosinophils are known to drive this process

  12. ASTHMA PATHOGENESIS • It is consequence of dysregulation of selective cytokine networks in the airways due to Th2 cells • Chronic mucosal inflammation, at least in part, leads to „airway remodeling”.

  13. ROLE OF MAST TRYPTASE IN ASTHMA Mast tryptase induces: • Bronchoconstriction and hyperresponsiveness • Stimulation of proliferation of fibroblasts, smooth muscle and epithelial cells • Generation of kinins • Stimulation of IL-8 release • Eosinophil chemotaxis

  14. TYPE II HYPERSENSTIVITY REACTIONS • Are caused by IgG and IgM antibodies directed against cell surface, extracellular matrix and intracellular antigens. The latter are usually non-pathogenic but diagnostically useful • Transfusion reactions to erythrocytes are due to antibodies to blood group antigens • The antibodies damage cells and tissues by activating complement and by binding and activating Fc receptor + effector cells

  15. TYPE II HYPERSENSITIVITY – EXAMPLES FROM PATHOLOGY • Hyperacute graft rejection • Hemolytic disease of the newborn (Rhesus D incompatibility) • Autoimmune hemolytic anemias • Goodpasture’s syndrome • Pemphigus • Myasthenia gravis • Lambert-Eaton syndrome

  16. CHARACTERISTICS OF IMMUNE COMPLEXES • Formed by the non-covalent union of antigen and antibody • Can be formed in the circulation or in tissues • Removed from the circulation by the host’s mononuclear phagocyte system • Can lodge in tissue, activate complement, and produce tissue damage • Tend to be solubilized by complement

  17. AGENTS IMPORTANT IN DEPOSITION AND CLEARANCE OF IMMUNE COMPLEXES • Complement deficiency impairs clearance • The size of IC affects their deposition • Immunoglobulin classes of IC affect the rate of their clearance (IgG vs. IgA)

  18. AGENTS IMPORTANT IN DEPOSITION AND CLEARANCE OF IMMUNE COMPLEXES • Phagocyte defects allow complexes to persist • An increase in vascular permeability, high blood pressure and local turbulence triggers deposition • Affinity of antigens for specific tissues may direct IC to particular sites

  19. THE VARIANTS OF TYPE IV (DELAYED) HYPERSENSITIVITY • Contact one–eczematous reaction at the point of contact with allergen, usually hapten, occurs within 72 hours of antigen challenge • Tuberculin one–an area of red firm swelling of the skin, 48-72 hrs after injection • Granulomatous one – formation of granuloma at 21-28 days following antigen exposure

  20. DISEASES WITH TYPE IV GRANULOMATOUS HYPERSENSITIVITY • Chronic pulmonary tuberculosis • Borderline leprosy • Sarcoidosis • Crohn’s disease • Schistosomiasis • Some fungal diseases

  21. THANK YOU!

More Related